Who
P. Sherrill Neff
Director
Company insider
Files Form 4 as: Director, ACRES Commercial Realty; Director and 10% owner, Cempra; Director and 10% owner, Regado Biosciences; Director, Amicus Therapeutics.
In numbers
- Trades disclosed
- 59
- Buys
- 4
- Sells
- 2
- Bought
- $9.4M
- Sold
- $181K
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 8 Mar 2006
- Last trade
- 6 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 7 Aug 2026 | ACR ACRES Commercial RealtyREITs | SEC FORM 4 Code A | —4,280 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | ACR ACRES Commercial RealtyREITs | SEC FORM 4 Code A | —4,280 at $0.00 | filing |
| 5 Mar 2026filed 6 Mar 2026 | ACR ACRES Commercial RealtyREITs | SEC FORM 4 Code A | —5,555 at $0.00 | filing |
| 5 Mar 2026filed 6 Mar 2026 | ACR ACRES Commercial RealtyREITs | SEC FORM 4 Code A | —5,555 at $0.00 | filing |
| 7 May 2024filed 8 May 2024 | ACR ACRES Commercial RealtyREITs | SEC FORM 4 Code A | —4,762 at $0.00 | filing |
| 6 May 2022filed 9 May 2022 | ACR ACRES Commercial RealtyREITs | SEC FORM 4 Code A | —4,762 at $0.00 | filing |
| 21 May 2021filed 21 May 2021 | ACR ACRES Commercial RealtyREITs | SEC FORM 4 Code A | —6,666 at $0.00 | filing |
| 9 Mar 2020filed 10 Mar 2020 | ACR ACRES Commercial RealtyREITs | SEC FORM 4 Code A | —3,944 at $0.00 | filing |
| 8 Mar 2019filed 12 Mar 2019 | ACR ACRES Commercial RealtyREITs | SEC FORM 4 Code A | —3,762 at $0.00 | filing |
| 8 Mar 2018filed 9 Mar 2018 | ACR ACRES Commercial RealtyREITs | SEC FORM 4 Code A | —4,347 at $0.00 | filing |
| 8 Mar 2017filed 9 Mar 2017 | ACR ACRES Commercial RealtyREITs | SEC FORM 4 Code A | —4,920 at $0.00 | filing |
| 5 Oct 2016filed 7 Oct 2016 | Cempra | SEC FORM 4 Code J | —1,000,000 at $0.00 | filing |
| 5 Oct 2016filed 7 Oct 2016 | Cempra | SEC FORM 4 Code J | —2,488 at $0.00 | filing |
| 8 Mar 2016filed 9 Mar 2016 | ACR ACRES Commercial RealtyREITs | SEC FORM 4 Code A | —3,710 at $0.00 | filing |
| 1 Jan 2016filed 5 Jan 2016 | Cempraoption or derivative | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 9 Mar 2015filed 10 Mar 2015 | ACR ACRES Commercial RealtyREITs | SEC FORM 4 Code A | —8,583 at $0.00 | filing |
| 1 Jan 2015filed 6 Jan 2015 | Regado Biosciencesoption or derivative | SEC FORM 4 Code A | —159,261 at $0.00 | filing |
| 1 Jan 2015filed 2 Jan 2015 | Cempraoption or derivative | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 10 Mar 2014filed 11 Mar 2014 | ACR ACRES Commercial RealtyREITs | SEC FORM 4 Code A | —6,872 at $0.00 | filing |
| 8 Jan 2014filed 10 Jan 2014 | Cempraoption or derivative | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
News
ACRES Commercial Realty (NYSE:ACR) versus Manhattan Bridge Capital (NASDAQ:LOAN) Critical SurveyACR · themarketsdaily.com · 14 Oct 2026
0 headlines in the last 90 days name P. Sherrill Neff; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.